258 related articles for article (PubMed ID: 18188417)
1. Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY.
Park SH; Cho CS; Lee OY; Jun JB; Lin SR; Zhou LY; Yuan YZ; Li ZS; Hou XH; Zhao HC; Kachintorn U; Kositchaiwat C; Lertkupinit C
J Clin Biochem Nutr; 2007 Mar; 40(2):148-55. PubMed ID: 18188417
[TBL] [Abstract][Full Text] [Related]
2. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
[TBL] [Abstract][Full Text] [Related]
3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
4. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
Hawkey CJ
Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449
[TBL] [Abstract][Full Text] [Related]
9. Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.
Zhang S; Qing Q; Bai Y; Mao H; Zhu W; Chen Q; Zhang Y; Chen Y
Dig Dis Sci; 2013 Jul; 58(7):1991-2000. PubMed ID: 23456504
[TBL] [Abstract][Full Text] [Related]
10. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
11. Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.
Lee KN; Lee OY; Choi MG; Choi SR; Lee DH; Lee YC; Kim TN; Choi SC; Rew JS; Seol SY
J Korean Med Sci; 2011 Aug; 26(8):1074-80. PubMed ID: 21860559
[TBL] [Abstract][Full Text] [Related]
12. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).
Yamao J; Kikuchi E; Matsumoto M; Nakayama M; Ann T; Kojima H; Mitoro A; Yoshida M; Yoshikawa M; Yajima H; Miyauchi Y; Ono H; Akiyama K; Sakurai G; Kinoshita Y; Haruma K; Takakura Y; Fukui H
J Gastroenterol; 2006 Dec; 41(12):1178-85. PubMed ID: 17287897
[TBL] [Abstract][Full Text] [Related]
13. Considerations for nonsteroidal anti-inflammatory drug therapy: safety.
Blower AL
Scand J Rheumatol Suppl; 1996; 105():13-24; discussion 25-7. PubMed ID: 8792807
[TBL] [Abstract][Full Text] [Related]
14. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
[TBL] [Abstract][Full Text] [Related]
15. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions.
Grazioli I; Avossa M; Bogliolo A; Broggini M; Carcassi A; Carcassi U; Cecconami L; Ligniere GC; Colombo B; Consoli G
Clin Exp Rheumatol; 1993; 11(3):289-94. PubMed ID: 8353983
[TBL] [Abstract][Full Text] [Related]
18. Challenges in managing NSAID-associated gastrointestinal tract injury.
Goldstein JL
Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
20. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
Hawkey CJ
Am J Med; 1998 Mar; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
